Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
The Journal of Clinical Investigation
|
July 2, 2010
Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants
Pak Cheung Ng, Irene Ling Ang, Rossa Wai Kwun Chiu, et al.
Pathogens (Basel, Switzerland)
|
April 23, 2022
Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study
Renee W Y Chan, Kate C C Chan, Grace C Y Lui, et al.
The EMBO Journal
|
May 17, 2024
Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS
Christopher J Carnie, Maximilian J Götz, Chloe S Palma-Chaundler, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Cell-stereotyped DNA repair outcomes are widespread during genome editing
Moritz F Schlapansky, Markus S Schröder, Antonio J Santinha, et al.
Nature Communications
|
October 9, 2025
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2
Jordan C J Wilson, JiaYi Zhu, Vanesa Vinciauskaite, et al.
Life Sciences
|
December 29, 2022
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Life Sciences
|
May 18, 2024
Retraction notice to "Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases" [Life Sci. 314 (2023) 121325]
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Translational Neurodegeneration
|
January 26, 2023
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
Brain Communications
|
January 16, 2025
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
JAMA Network Open
|
June 2, 2026
The Phoenix Criteria and Other Severity Scores in Identifying Pediatric Sepsis
Shuhua He, Jack Zhenhe Zhang, Lawrence Chi-Ngong Chan, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
The Journal of Clinical Investigation
|
July 2, 2010
Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants
Pak Cheung Ng, Irene Ling Ang, Rossa Wai Kwun Chiu, et al.
Pathogens (Basel, Switzerland)
|
April 23, 2022
Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study
Renee W Y Chan, Kate C C Chan, Grace C Y Lui, et al.
The EMBO Journal
|
May 17, 2024
Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS
Christopher J Carnie, Maximilian J Götz, Chloe S Palma-Chaundler, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Cell-stereotyped DNA repair outcomes are widespread during genome editing
Moritz F Schlapansky, Markus S Schröder, Antonio J Santinha, et al.
Nature Communications
|
October 9, 2025
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2
Jordan C J Wilson, JiaYi Zhu, Vanesa Vinciauskaite, et al.
Life Sciences
|
December 29, 2022
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Life Sciences
|
May 18, 2024
Retraction notice to "Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases" [Life Sci. 314 (2023) 121325]
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Translational Neurodegeneration
|
January 26, 2023
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
Brain Communications
|
January 16, 2025
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
JAMA Network Open
|
June 2, 2026
The Phoenix Criteria and Other Severity Scores in Identifying Pediatric Sepsis
Shuhua He, Jack Zhenhe Zhang, Lawrence Chi-Ngong Chan, et al.
Page
of 18